Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IMPOSSIBREW is a UK-based functional beverage company that develops non-alcoholic beers enhanced with a proprietary blend of nootropics and adaptogens. Founded by Mark Wong, the company's "Social Blend" utilizes active ingredients like L-Theanine and Ashwagandha to provide relaxation and social benefits without the negative effects of alcohol. The company gained significant attention following an appearance on the BBC's Dragon's Den and has since expanded its product line to include various styles of beer. IMPOSSIBREW positions itself at the intersection of the "sober curious" movement and the growing market for cognitive-enhancing supplements. The brand focuses on the physiological effects of its ingredients, targeting the GABAergic system to mimic the relaxing qualities of ethanol. By combining traditional brewing techniques with modern nutritional science, the company offers a health-conscious alternative for social drinking.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IMPOSSIBREW.